NICE publishes final appraisal determination for Alecensa

8 August 2018 - The determination relates to the use of alectinib hydrochloride for the first-line treatment of patients with untreated ...

Read more →

UK unveils plans for bigger medicines price squeeze

7 August 2018 - Company payments to government would rise steeply to 2021. ...

Read more →

Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC—does the presence of an explicit threshold affect the ICER proposed?

8 August 2018 - The English NICE and the Australian PBAC require evidence that a new medicine represents value for money ...

Read more →

NZ's cancer death rates worse than Australia's due to medicine inaccessibility - oncologist

7 August 2018 - The number of cancer deaths may increase if the country's approach to the disease isn't urgently ...

Read more →

‘Survival of the richest’: Rich access drugs PHARMAC won’t fund

7 August 2018 - Oncologists including the cancer society's top doctor say the government's drug agency, PHARMAC, is failing to keep ...

Read more →

Health insurance discounts will benefit only the young rich: consumer groups

7 August 2018 - The proposed private health insurance discounts for young people will benefit only rich young people and ...

Read more →

PHARMAC takes three years to review brand-new cancer drugs and Kiwis are missing out

7 August 2018 - Kiwis are missing out on the latest cancer treatments because the government's drug agency, PHARMAC, is ...

Read more →

Government looks to include biosimilars in price controls

7 August 2018 - The government has launched consultation on proposed changes to the statutory scheme for pharmaceutical pricing that ...

Read more →

Health insurance needs in-depth scrutiny in the public interest

7 August 2018 - Discounts on health insurance premiums for young people under 30 would erode the community-sharing principles of ...

Read more →

Division on European HTA

3 August 2018 - There have been aspirations for closer collaboration between European Union Member States on health technology assessment for ...

Read more →

Glatect, alternative to Copaxone, added to public health plans of 5 Canadian provinces

6 August 2018 - Pendopharm’s Glatect (glatiramer acetate injection), a lower cost alternative to Teva’s Copaxone, has been added to ...

Read more →

Government urged to dump 'flawed' health insurance discount plan for young people

7 August 2018 - The federal government is being urged to scrap its plan to allow health insurance companies to ...

Read more →

Private Health Insurance 'excluding benefits under the radar'

4 August 2018 - Doctors are warning that the federal government's private health insurance reforms may push patients onto public ...

Read more →

Duncan Garner's desperate plea to Jacinda Ardern over cancer funding

7 August 2018 - "There are people dying, mums and dads and brothers and sisters." ...

Read more →

Supply of anti-retroviral treatments

6 August 2018 - PHARMAC invites tenders for the supply of certain antiretroviral treatments to DHB hospitals and to community pharmacies ...

Read more →